Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer's disease pathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Alzheimer'S Research & Therapy|February 4, 2023
Correction: Cortical microstructure in primary progressive aphasia: a multicenter studyIgnacio Illán-Gala, Victor Montal, Sergi Borrego-Écija, et al.
The Lancet. Neurology|July 24, 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort studyMaria Carmona-Iragui, Daniel Alcolea, Isabel Barroeta, et al.
Plos One|May 26, 2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease riskMuhammad Ali, Yun Ju Sung, Fengxian Wang, et al.
JAMA Neurology|January 22, 2024
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAlejandra O Morcillo-Nieto, Mateus Rozalem Aranha, José Enrique Arriola-Infante, et al.
Sleep|August 30, 2016
Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal ElderlyAndrew W Varga, Margaret E Wohlleber, Sandra Giménez, et al.
Lancet (London, England)|June 29, 2020
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, Eduard Vilaplana, Maria Carmona-Iragui, et al.
Human Molecular Genetics|September 24, 2013
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementiaOriol Dols-Icardo, Alberto García-Redondo, Ricard Rojas-García, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2021
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluidJohan Gobom, Lucilla Parnetti, Pedro Rosa-Neto, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer's disease pathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Alzheimer'S Research & Therapy|February 4, 2023
Correction: Cortical microstructure in primary progressive aphasia: a multicenter studyIgnacio Illán-Gala, Victor Montal, Sergi Borrego-Écija, et al.
The Lancet. Neurology|July 24, 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort studyMaria Carmona-Iragui, Daniel Alcolea, Isabel Barroeta, et al.
Plos One|May 26, 2022
Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease riskMuhammad Ali, Yun Ju Sung, Fengxian Wang, et al.
JAMA Neurology|January 22, 2024
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAlejandra O Morcillo-Nieto, Mateus Rozalem Aranha, José Enrique Arriola-Infante, et al.
Sleep|August 30, 2016
Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal ElderlyAndrew W Varga, Margaret E Wohlleber, Sandra Giménez, et al.
Lancet (London, England)|June 29, 2020
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional studyJuan Fortea, Eduard Vilaplana, Maria Carmona-Iragui, et al.
Human Molecular Genetics|September 24, 2013
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementiaOriol Dols-Icardo, Alberto García-Redondo, Ricard Rojas-García, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2021
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluidJohan Gobom, Lucilla Parnetti, Pedro Rosa-Neto, et al.
Pageof 25